NVS
Income statement / Annual
Last year (2024), Novartis AG's total revenue was $51.72 B,
an increase of 10.85% from the previous year.
In 2024, Novartis AG's net income was $11.94 B.
See Novartis AG,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$51.72 B |
$46.66 B |
$51.83 B |
$52.88 B |
$49.90 B |
$48.68 B |
$53.17 B |
$50.14 B |
$49.44 B |
$50.39 B |
| Cost of Revenue |
$12.83 B
|
$12.47 B
|
$15.49 B
|
$15.87 B
|
$15.12 B
|
$14.43 B
|
$18.41 B
|
$17.18 B
|
$17.52 B
|
$17.40 B
|
| Gross Profit |
$38.90 B
|
$34.19 B
|
$36.34 B
|
$37.01 B
|
$34.78 B
|
$34.25 B
|
$34.76 B
|
$32.96 B
|
$31.92 B
|
$32.98 B
|
| Gross Profit Ratio |
0.75
|
0.73
|
0.7
|
0.7
|
0.7
|
0.7
|
0.65
|
0.66
|
0.65
|
0.65
|
| Research and Development Expenses |
$10.02 B
|
$11.37 B
|
$10.00 B
|
$9.54 B
|
$8.98 B
|
$9.40 B
|
$9.07 B
|
$8.97 B
|
$9.04 B
|
$8.94 B
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$16.47 B
|
$2.14 B
|
$2.19 B
|
$2.48 B
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$12.86 B
|
$12.00 B
|
$11.77 B
|
| Selling, General & Administrative Expenses |
$12.57 B
|
$12.49 B
|
$14.25 B
|
$14.89 B
|
$14.20 B
|
$14.37 B
|
$16.47 B
|
$15.00 B
|
$14.19 B
|
$14.25 B
|
| Other Expenses |
$1.76 B
|
$559.00 M
|
$2.90 B
|
$895.00 M
|
$1.45 B
|
$1.40 B
|
$1.05 B
|
$362.00 M
|
$417.00 M
|
$824.00 M
|
| Operating Expenses |
$24.35 B
|
$24.42 B
|
$27.15 B
|
$25.32 B
|
$24.63 B
|
$25.17 B
|
$26.59 B
|
$24.33 B
|
$23.65 B
|
$24.01 B
|
| Cost And Expenses |
$37.18 B
|
$36.89 B
|
$42.63 B
|
$41.19 B
|
$39.75 B
|
$39.59 B
|
$45.00 B
|
$41.51 B
|
$41.17 B
|
$41.41 B
|
| Interest Income |
$568.00 M
|
$627.00 M
|
$379.00 M
|
$71.00 M
|
$91.00 M
|
$245.00 M
|
$294.00 M
|
$110.00 M
|
$43.00 M
|
$33.00 M
|
| Interest Expense |
$1.01 B
|
$855.00 M
|
$837.00 M
|
$811.00 M
|
$869.00 M
|
$850.00 M
|
$957.00 M
|
$777.00 M
|
$707.00 M
|
$655.00 M
|
| Depreciation & Amortization |
$6.07 B
|
$8.28 B
|
$6.71 B
|
$5.43 B
|
$5.11 B
|
$5.83 B
|
$5.21 B
|
$5.21 B
|
$5.35 B
|
$5.58 B
|
| EBITDA |
$20.72 B |
$18.29 B |
$14.73 B |
$17.13 B |
$15.24 B |
$15.01 B |
$14.14 B |
$13.90 B |
$13.19 B |
$14.36 B |
| EBITDA Ratio |
0.4
|
0.39
|
0.32
|
0.63
|
0.34
|
0.32
|
0.41
|
0.32
|
0.3
|
0.29
|
| Operating Income Ratio |
0.28
|
0.21
|
0.18
|
0.51
|
0.2
|
0.19
|
0.15
|
0.17
|
0.17
|
0.18
|
| Total Other Income/Expenses Net |
-$904.00 M
|
-$646.00 M
|
$425.00 M
|
-$16.15 B
|
-$274.00 M
|
-$146.00 M
|
-$746.00 M
|
-$811.00 M
|
-$451.00 M
|
-$843.00 M
|
| Income Before Tax |
$13.64 B
|
$9.12 B
|
$8.37 B
|
$26.14 B
|
$9.88 B
|
$8.94 B
|
$13.84 B
|
$9.00 B
|
$7.82 B
|
$8.13 B
|
| Income Before Tax Ratio |
0.26
|
0.2
|
0.16
|
0.49
|
0.2
|
0.18
|
0.26
|
0.18
|
0.16
|
0.16
|
| Income Tax Expense |
$1.70 B
|
$551.00 M
|
$1.42 B
|
$2.12 B
|
$1.81 B
|
$1.79 B
|
$1.22 B
|
$1.30 B
|
$1.12 B
|
$1.11 B
|
| Net Income |
$11.94 B
|
$14.85 B
|
$6.96 B
|
$24.02 B
|
$8.07 B
|
$7.15 B
|
$12.61 B
|
$7.70 B
|
$6.71 B
|
$17.78 B
|
| Net Income Ratio |
0.23
|
0.32
|
0.13
|
0.45
|
0.16
|
0.15
|
0.24
|
0.15
|
0.14
|
0.35
|
| EPS |
5.97 |
7.15 |
3.19 |
10.71 |
3.54 |
3.12 |
5.44 |
3.28 |
2.82 |
7.4 |
| EPS Diluted |
5.87 |
7.1 |
3.17 |
10.63 |
3.52 |
3.08 |
5.38 |
3.25 |
2.8 |
7.29 |
| Weighted Average Shares Out |
$2.00 B
|
$2.08 B
|
$2.18 B
|
$2.24 B
|
$2.28 B
|
$2.29 B
|
$2.32 B
|
$2.35 B
|
$2.38 B
|
$2.40 B
|
| Weighted Average Shares Out Diluted |
$2.04 B
|
$2.09 B
|
$2.20 B
|
$2.26 B
|
$2.30 B
|
$2.32 B
|
$2.34 B
|
$2.37 B
|
$2.40 B
|
$2.44 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
